Forbes Daily Briefing podcast

How This New Biotech Billionaire Outmaneuvered Merck In China

0:00
4:54
Spol 15 sekunder tilbage
Spol 15 sekunder frem

Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a trial last year, the firm’s cancer drug outperformed the world’s best seller–and its surging stock just made her a billionaire.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Flere episoder fra "Forbes Daily Briefing"